FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

428384006: Ciprofloxacin lactate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2689709018 Ciprofloxacin lactate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2691843017 Ciprofloxacin lactate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
801061000172118 lactate de ciprofloxacine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ciprofloxacin lactate (substance) Is a Ciprofloxacin (substance) false Inferred relationship Some
Ciprofloxacin lactate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Ciprofloxacin (substance) true Inferred relationship Some
Ciprofloxacin lactate (substance) Is a Quinolone antibacterial false Inferred relationship Some
Ciprofloxacin lactate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Ciprofloxacin lactate (substance) Is a Fluoroquinolone (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 200 milligram/100 milliliter conventional release solution for infusion bag The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin lactate (substance) Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 400 milligram/200 milliliter conventional release solution for infusion bag The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin lactate (substance) Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 100 milligram/50 milliliter conventional release solution for infusion bottle The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Ciprofloxacin lactate (substance) Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for infusion (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin lactate (substance) Inferred relationship Some 1
Ciprofloxacin (as ciprofloxacin lactate) 2 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin lactate (substance) Inferred relationship Some 1
Product containing precisely ciprofloxacin (as ciprofloxacin lactate) 2 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ciprofloxacin lactate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start